Literature DB >> 25846270

Rikkunshito induces gastric relaxation via the β-adrenergic pathway in Suncus murinus.

A Mondal1, A Takehara1, S Aizawa1, T Tanaka2, N Fujitsuka3, T Hattori3, T Sakai1, I Sakata1.   

Abstract

BACKGROUND: Rikkunshito (RKT) is a gastroprotective herbal medicine. In this study, we investigated the role of RKT in the relaxation of the gastric body (fundus and corpus) and antrum.
METHODS: We used Suncus murinus, a unique small model animal with similar gastrointestinal motility to humans and dogs. RKT was added at 0.1, 1.0, and 5.0 mg/mL to induce relaxation in vitro; the outcome measure was the intensity of relaxation. The number of spontaneous antral contractions in the absence or the presence of RKT was also counted. KEY
RESULTS: Rikkunshito induced the relaxation of the gastric body and antrum and decreased the number of spontaneous antral contractions in a dose-dependent manner. The responses to RKT (1.0 mg/mL) were not affected by pretreatment with atropine, N-nitro-l-arginine methyl ester, ritanserin, or ondansetron. On the other hand, timolol almost completely reversed the relaxation induced by RKT (1.0 mg/mL) on the gastric body and antrum and the occurrence of the spontaneous antral contractions. Both butoxamine, a β(2) -adrenoreceptor antagonist, and L 748337, a β(3) -adrenoreceptor antagonist, but not CGP 20712, a β(1) -adrenoreceptor antagonist, significantly reversed the RKT-induced (1.0 mg/mL) gastric relaxation. CONCLUSIONS & INFERENCES: These results indicate that RKT stimulates and modulates gastric relaxation through β(2) - and β(3) -adrenergic, but not β(1) -adrenergic, pathways in S. murinus.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Rikkunshito; adrenergic receptor; gastric relaxation

Mesh:

Substances:

Year:  2015        PMID: 25846270     DOI: 10.1111/nmo.12564

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  2 in total

Review 1.  Management of functional dyspepsia: state of the art and emerging therapies.

Authors:  Hiroshi Yamawaki; Seiji Futagami; Mako Wakabayashi; Noriko Sakasegawa; Shuhei Agawa; Kazutoshi Higuchi; Yasuhiro Kodaka; Katsuhiko Iwakiri
Journal:  Ther Adv Chronic Dis       Date:  2017-08-27       Impact factor: 5.091

Review 2.  Ghrelin Enhancer, the Latest Evidence of Rikkunshito.

Authors:  Chihiro Yamada; Tomohisa Hattori; Shunsuke Ohnishi; Hiroshi Takeda
Journal:  Front Nutr       Date:  2021-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.